https://www.ansm.sante.fr/actualites/acetate-de-nomegestrol-lutenyl-et-generiques-acetate-de-chlormadinone-luteran-et-generiques-et-risque-de-meningiome-recommandations-dutilisation-et-de-suivi-des-patientes 2021 false false false France French guidelines for drug use continuity of patient care drug monitoring Drug-Related side effects and adverse reactions nomegestrol acetate nomegestrol chlormadinone chlormadinone acetate risk meningioma risk assessment meningioma chlormadinone acetate megestrol norpregnadienes
--- https://ansm.sante.fr/informations-de-securite/nouvelles-conditions-de-prescription-et-de-delivrance-des-specialites-a-base-dacetate-de-nomegestrol-lutenyl-et-generiques-et-dacetate-de-chlomadinone-luteran-et-generiques-liees-au-risque-de-meningiome 2021 false false false France French meningioma guidelines for drug use nomegestrol acetate nomegestrol acetate chlormadinone acetate chlormadinone acetate risk management chlormadinone acetate chlormadinone acetate megestrol norpregnadienes megestrol norpregnadienes
--- https://ansm.sante.fr/actualites/lutenyl-luteran-et-risque-de-meningiome-appel-a-participation-en-vue-dune-consultation-publique-1 2020 false false false France French nomegestrol acetate drug information chlormadinone acetate chlormadinone nomegestrol meningioma chlormadinone acetate megestrol norpregnadienes
--- https://www.ansm.sante.fr/actualites/lutenyl-luteran-et-generiques-recommandations-preliminaires-suite-a-la-confirmation-du-sur-risque-de-meningiome 2020 false false false France French pharmacovigilance note guidelines for drug use meningioma nomegestrol acetate chlormadinone acetate administration, oral chlormadinone nomegestrol risk patients guideline chlormadinone acetate megestrol norpregnadienes
--- http://www.has-sante.fr/portail/jcms/c_2612652/fr/luteran http://www.has-sante.fr/portail/jcms/c_923058/luteran 2016 false France French chlormadinone acetate premenopause progesterone hormone replacement therapy chlormadinone acetate administration, oral insurance, health, reimbursement chlormadinone progesterone congeners evaluation of the transparency committee